BNP Paribas Financial Markets’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-86,869
| Closed | -$19.2M | – | 5854 |
|
|
2025
Q4 | $19.2M | Buy |
86,869
+82,410
| +1,848% | +$13.3M | 0.01% | 1207 |
|
|
2025
Q3 | $427K | Buy |
4,459
+2,641
| +145% | +$169K | ﹤0.01% | 3624 |
|
|
2025
Q2 | $88.6K | Buy |
1,818
+1,801
| +10,594% | +$43.3K | ﹤0.01% | 4059 |
|
|
2025
Q1 | $366 | Hold |
17
| – | – | ﹤0.01% | 5164 |
|
|
2024
Q4 | $457 | Hold |
17
| – | – | ﹤0.01% | 5180 |
|
|
2024
Q3 | $183 | Hold |
17
| – | – | ﹤0.01% | 4045 |
|
|
2024
Q2 | $203 | Sell |
17
-1
| -6% | -$14 | ﹤0.01% | 3933 |
|
|
2024
Q1 | $325 | Hold |
18
| – | – | ﹤0.01% | 3921 |
|
|
2023
Q4 | $280 | Hold |
18
| – | – | ﹤0.01% | 3915 |
|
|
2023
Q3 | $333 | Hold |
18
| – | – | ﹤0.01% | 3803 |
|
|
2023
Q2 | $399 | Hold |
18
| – | – | ﹤0.01% | 3802 |
|
|
2023
Q1 | $448 | Hold |
18
| – | – | ﹤0.01% | 3724 |
|
|
2022
Q4 | $267 | Hold |
18
| – | – | ﹤0.01% | 3909 |
|
|
2022
Q3 | $222 | Hold |
18
| – | – | ﹤0.01% | 4600 |
|
|
2022
Q2 | $172 | Hold |
18
| – | – | ﹤0.01% | 4004 |
|
|
2022
Q1 | $294 | Sell |
18
-9
| -33% | -$153 | ﹤0.01% | 4065 |
|
|
2021
Q4 | $681 | Sell |
27
-9
| -25% | -$280 | ﹤0.01% | 4087 |
|
|
2021
Q3 | $1.59K | Hold |
36
| – | – | ﹤0.01% | 3827 |
|
|
2021
Q2 | $1.43K | Sell |
36
-267
| -88% | -$11.3K | ﹤0.01% | 3914 |
|
|
2021
Q1 | $16.1K | Sell |
303
-13
| -4% | -$642 | ﹤0.01% | 3787 |
|
|
2020
Q4 | $12.7K | Sell |
316
-68
| -18% | -$3.38K | ﹤0.01% | 3905 |
|
|
2020
Q3 | $21.9K | Buy |
384
+321
| +510% | +$22.7K | ﹤0.01% | 3804 |
|
|
2020
Q2 | $4.62K | Buy |
+63
| New | +$4.08K | ﹤0.01% | 4037 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 4295 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 4397 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 4492 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 4518 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4257 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4300 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4410 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 4385 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 4192 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 4177 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 4183 |
|
|
2017
Q2 | – | Sell |
-3
| Closed | -$415 | – | 4210 |
|
|
2017
Q1 | $484 | Sell |
3
-8
| -73% | -$1.41K | ﹤0.01% | 3854 |
|
|
2016
Q4 | $2.28K | Sell |
11
-26
| -70% | -$5.4K | ﹤0.01% | 3901 |
|
|
2016
Q3 | $8.36K | Buy |
37
+16
| +76% | +$3.7K | ﹤0.01% | 3257 |
|
|
2016
Q2 | $4.38K | Buy |
+21
| New | +$5.08K | ﹤0.01% | 3321 |
|
|
2016
Q1 | – | Sell |
-23
| Closed | -$7.83K | – | 2727 |
|
|
2015
Q4 | $7.83K | Sell |
23
-27
| -54% | -$8.11K | ﹤0.01% | 3282 |
|
|
2015
Q3 | $12.7K | Buy |
+50
| New | +$14.3K | ﹤0.01% | 3404 |
|
BNP Paribas Financial Markets's CDTX Position: Q1 2026 in Review
BNP Paribas Financial Markets sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 86,869 shares — an estimated $19.2M sold.
BNP Paribas Financial Markets first reported a position in CDTX in Q3 2015 and held it in 29 quarters. The position peaked at $19.2M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.
- BNP Paribas Financial Markets reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
- BNP Paribas Financial Markets sold 86,869 Cidara Therapeutics shares in Q1 2026, an estimated $19.2M.
- BNP Paribas Financial Markets first reported a position in Cidara Therapeutics in Q3 2015 and held it in 29 quarters.
- BNP Paribas Financial Markets's Cidara Therapeutics position peaked at $19.2M in Q4 2025.
- 0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.